Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys

Marcel M. Daadi, Phillip Pivirotto, John Bringas, Janet Cunningham, John Forsayeth, Jamie Eberling, Krys S. Bankiewicz

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

The present report describes for the first time, the stability of recombinant adeno-associated virus serotype 2 (AAV2) human aromatic L-amino acid decarboxylase (hAADC) gene transfer after 3-year survival time in a non-human primate model of Parkinson's disease. 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned monkeys were treated with six injections of 30 μl/site of AAV2-hAADC at a concentration of 2 × 1012 vg/ml into the caudate and putamen. Stereological analysis revealed a 46.6% increase in the total number of AAV2-hAADC-transduced cells in the striatum between 8 weeks and 3 years after gene transfer survival time. In the 8-week animals, the distribution of the AADC + cells was dispersed and heterogeneous, whereas in the 3-year animals it was widespread and homogenous. Confocal analysis demonstrated that approximately 85% of the AADC+ cells were neuronal nuclei immunoreactive.

Original languageEnglish (US)
Pages (from-to)201-204
Number of pages4
JournalNeuroReport
Volume17
Issue number2
DOIs
StatePublished - Feb 2006
Externally publishedYes

Keywords

  • Gene therapy
  • Long-term gene transfer
  • Monkey MPTP
  • Parkinson's disease
  • Recombinant adeno-associated virus serotype 2
  • Stereology

ASJC Scopus subject areas

  • General Neuroscience

Fingerprint

Dive into the research topics of 'Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys'. Together they form a unique fingerprint.

Cite this